Continuous B cell destruction and regeneration is crucial for effective response to anti CD19 CAR-T cell therapy

被引：0
|
作者：
Nevo, Neta [1 ]
Milman, Neta [1 ]
Cooper, Tim J. [1 ]
Zuckerman, Tsila [2 ]
Shen-Orr, Shai S. [1 ]
机构：
[1] Technnion, Haifa, Israel
[2] Rambam Med Ctr, Haifa, Israel
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2024年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1156 - P1.
引用
收藏
页码：761 / 761
页数：1
相关论文
共 50 条
  • [31] Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy
    Lihong An
    Yuehui Lin
    Biping Deng
    Zhichao Yin
    Defeng Zhao
    Zhuojun Ling
    Tong Wu
    Yongqiang Zhao
    Alex H. Chang
    Chunrong Tong
    Shuangyou Liu
    BMC Cancer, 22
  • [32] Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy
    Chou, Cassie K.
    Turtle, Cameron J.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (06) : 653 - 664
  • [33] Effects of glucocorticoids on the proliferation of CD19 CAR-T cells targeting B-cell tumor cell lines
    邓昊彬
    China Medical Abstracts(Internal Medicine), 2022, 39 (01) : 58 - 59
  • [34] Functional drivers of resistance to anti-CD19 CAR-T cell therapy in diffuse large B cell lymphoma
    Newsam, Austin D.
    Coughlin, Caroline A.
    Trabolsi, Asaad
    Schatz, Jonathan H.
    LEUKEMIA & LYMPHOMA, 2023, 64 (14) : 2217 - 2224
  • [35] Clinical Trial of CD19 CAR-T Cell Therapy with non-virus Vector System
    Takahashi, Yoshiyuki
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S3 - S3
  • [36] Development of KYV-101, a Novel CD19 CAR-T Cell Therapy for the Treatment of B Cell-Driven Autoimmune Diseases
    Kaplan, Charles
    Park, Soo
    O'Brien, Erin
    Register, Ames
    Dong, Catherine
    Anaya, Daniel
    Lee, Ho-Young
    Borie, Dominic C.
    Chung, James
    Van Blarcom, Tom
    MOLECULAR THERAPY, 2023, 31 (04) : 319 - 319
  • [37] Long-Term Follow-up of Humanized and Murine CD19 CAR-T Cell Therapy for B-Cell Malignancies
    Zhang, Yinqiang
    Du, Mengyi
    Liao, Danying
    Xie, Wei
    Xiong, Wei
    Mei, Heng
    BLOOD, 2023, 142
  • [38] Feasibility of autologous stem cell transplantation as bridging therapy prior to cd19 car-t in r/r large b cell lymphoma
    Galli, E.
    Sora, F.
    Hohaus, S.
    Bellesi, S.
    Autore, F.
    Limongiello, M. A.
    Innocenti, I.
    Metafuni, E.
    Giammarco, S.
    Laurenti, L.
    Chiusolo, P.
    Bacigalupo, A.
    Sica, S.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 143 - 144
  • [39] Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma
    Roddie, Claire
    Neill, Lorna
    Osborne, Wendy
    Iyengar, Sunil
    Tholouli, Eleni
    Irvine, David
    Chaganti, Sridhar
    Besley, Caroline
    Bloor, Adrian
    Jones, Ceri
    Uttenthal, Ben
    Johnson, Rod
    Sanderson, Robin
    Cheok, Kathleen
    Marzolini, Maria
    Townsend, William
    O'Reilly, Maeve
    Kirkwood, Amy A.
    Kuhnl, Andrea
    BLOOD ADVANCES, 2023, 7 (12) : 2872 - 2883
  • [40] Rapid identification of early infections in febrile patients after CD19 target CAR-T cell therapy for B-cell malignancies
    Pu, Lian-Fang
    Zheng, Hui-Min
    Feng, Xiang-Jiang
    Charwudzi, Alice
    Liang, Xue
    Hu, Lin-Hui
    Ding, Yang-Yang
    Liu, Ze-Lin
    Liao, Ya
    Xiong, Shu-Dao
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
12345